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VITAMIN B12 DEFICIENCY—A MAJOR CAUSE OF MEGALOBLASTIC
ANAEMIA IN PATIENTS ATTENDING A TERTIARY CARE HOSPITAL
Saira Perwaiz Iqbal, Ghulam Nabi Kakepoto, Saleem Perwaiz Iqbal*
Department of Pathology and Microbiology, *Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan

Background: Folate and vitamin B12 deficiencies have been known to cause megaloblastic anaemia.
Since the deficiencies of these two vitamins are very common in Pakistani population, it would be
imperative to investigate their role in causing megaloblastic anaemia. The objective of this study was to
find out the contribution of folate and vitamin B12 deficiencies in causing megaloblastic anaemia in our
patient population. Methods: In this retrospective cohort study, clinical records of 220 patients (101
females and 119 males with an age range of 1–80 years) who presented themselves with macrocytic
anaemia at the Aga Khan University Hospital were collected. Data pertaining to complete blood count
and serum levels of folate and vitamin B12 were analysed. Results: The mean haemoglobin (Hb) level
was 6.8±0.2 gm/dl. Sixty-nine percent of the patients had severe anaemia (Hb<8 gm/dl). Mean±SEM
values of haemoglobin, serum folate and serum B12 were not significantly different between males and
females (Hb 6.4±0.3 gm/dl vs 6.3±0.3 gm/dl; folate 6.9±0.8 ηg/ml vs 7.8±1 ηg/ml; B12 259±65 ρg/ml
vs 225±45 ρg/ml, respectively). Linear regression analysis showed that serum folate was inversely
related with the mean corpuscular volume (MCV, p=0.04). Spearman’s correlation analysis indicated
an inverse mild association between MCV and serum folate (correlation coefficient= -0.18). Folate
deficiency was 43.4%, while vitamin B12 deficiency was 78.5% in these patients. Seventy-one percent
of folate-deficient patients had vitamin B12 deficiency as well, while 26.1% of patients with B12
deficiency had a co-occurrence of folate deficiency. Conclusion: Vitamin B12 deficiency appears to be
the major factor leading to megaloblastic anaemia in our study population. Inadequate dietary intake,
over-cooking of our food and poor absorption might be contributing to high prevalence of vitamin B12
deficiency in this population.
Keywords: Cobalamin deficiency, folate deficiency, macrocytic anaemia, megaloblastic anaemia,
nutritional anaemia, vitamin B12 deficiency, Pakistan

INTRODUCTION
Deficiencies of folic acid and vitamin B12 are known to
cause megaloblastic anaemia, an anaemia which is
characterised by presence of abnormally large
erythrocyte precursor cells, megaloblasts, in the bone
marrow and macrocytic red cells in the peripheral
blood.1 These megaloblasts arise because of impaired
DNA synthesis followed by ineffective erythropoiesis.1
Megaloblastic anaemia is frequently seen in
clinical practice in Pakistan.2,3 however, there have been
only a few comprehensive reports regarding its
prevalence, causative factors and associated symptoms
in Indo-Pak subcontinent.2–6 We had reported previously
that vitamin B12 deficiency was the major cause of
megaloblastic anaemia in patients who had been treated
at the Aga Khan University Hospital for anaemias of
vitamin deficiencies.2 Since then, there have been hardly
any detailed studies in this region on role of folate and
vitamin B12 in causing megaloblastic anaemia. The
objective of the present study was to find out the
contribution of folate and B12 deficiencies in causing
megaloblastic anaemia in our patient population.

PATIENT AND METHODS
It is a retrospective cohort study. Demographic and
clinical information of 220 patients (age 1–80 years)
with macrocytic anaemia who had been treated with B
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vitamins for anaemias at the Haematology Clinic of
the Aga Khan University Hospital (AKUH) during the
past 15 years (Jan 1989 to Jun 2004) was obtained
from the Department of Health Information
Management Services, AKUH. The diagnosis of
macrocytic anaemia was based on mean corpuscular
volume >96 fl and history of the physical examination.
Blood counts were performed with a Coulter Counter.
Anaemic patients with the primary disease, such as
hepatic disease, haemolytic anaemia, cancer, aplastic
anaemia, myeloproliferative disease, red cell aplasia,
multiple myeloma, leukaemia, chronic lung disease,
chronic kidney disease and those using immunosuppressive or chemotherapeutic drugs were excluded
from the study. Pregnant females, alcoholics and
children below the age of 1 year were also excluded.
Serum levels of folic acid and vitamin B12 had been
carried out by the Dual Count Kit (Diagnostic Products
Corporation, Los Angeles, CA, USA) using proper
controls. Vitamin B12 deficiency, was defined as serum
levels of B12 200 ρg/ml. Folate deficiency was
defined as serum levels of folic acid 3.5 ηg/ml.
Samples having border-line values of these vitamins
were repeated. The study had been approved by the
Ethics Review Committee of the Institution.
All analyses were performed on SPSS.
Values of quantitative variables were presented as
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Means±SEM, while proportions were given for
categorical characteristics. Chi-square analysis was
used to compare percent patients with vitamin
deficiency with percent patients with vitamin-normal
status. Linear regression analysis was performed to
determine the nature of relationship between levels of
vitamin B12, folate and haemoglobin with mean
carpuscular volume (MCV), adjusted for age.
Correlation between these quantitative variables was
assessed using Spearman’s rank correlation test and
p<0.05 was considered significant.

RESULTS
Demographic and clinical characteristics have been
shown in Table-1. Nearly 94% (n=204) of the patients
were non-vegetarians. Bone marrow examination
revealed that most of the patients had significant
megaloblastosis. Mean age of male patients was
marginally significant compared to female patients. In
terms of haemoglobin concentration, serum folate and
vitamin B12 levels, there were no significant
differences between males and females. Percent folate
and vitamin B12 deficiencies were 43.4% and 78.5%,
respectively (Table-2), while among the vegetarians,
percent vitamin B12 deficiency was nearly 85%.
Seventy one percent of folate-deficient patients had
vitamin B12 deficiency as well, while 26.1% of vitamin
B12-deficient patients were having a co-occurrence of
folate deficiency. Linear regression analysis revealed
inverse relationship between serum folate and MCV
(p=0.04). Strength of this relationship was determined
using Spearman’s correlation test which indicated an
inverse mild association between serum folate and
MCV correlation coefficient= -0.18; (Table-3).
Table-1: Demographic and clinical characteristics
of patients Mean±SEM
Variable
Total
Male
Female p-value*
Age (years)
38.9±1.8 42.6±3.4 36.7±3.6
0.05
Haemoglobin (g/dl)
6.8±0.2 6.4±0.3 6.3±0.3
0.81
MCV (fl)
103.5±1.1 106.2±1.8 104.1±2.1
0.13
Serum vitamin B12 (pg/ml) 246.6±33 225±45 259±65
0.48
Serum folate (ng/ml)
7.5±0.6 6.9±0.8 7.8±1.0
0.84
*p-value compares the Mean±SEM values of males and females by
Independent samples t-test.

Table-2: Frequency distribution of patients with
respect to their B vitamin status
Total
Male
Female
Vitamin B status
n(%)
n(%)
n(%) p-value**
Folate
-Deficiency (≤3.5 ηg/ml) 56*(43.4) 32(43.8) 24(42.8)
0.13
-Normal (>3.5 ηg/ml)
73(56.6) 41(56.2) 32 (57.2)
Vitamin B12
-Deficiency (≤200 ρg/ml) 153*78.5) 86(79.6) 67(77.0) <0.001
-Normal (>200 ρg/ml)
42(21.5) 22(20.4) 20(23.0)
*40 patients in each of these groups had deficiencies of both folate
and vitamin B12. **Test of proportions using chi square was used
to compare folate-deficient patients with folate-normal patients and
B12-deficient patients with B12-normal patients.

Table-3: Correlations of age, haemoglobin,
vitamin B12 and folate with MCV
Correlation
Variable
Coefficient*
p-value
Age (years)
0.14
0.31
Haemoglobin (g/dl)
-0.13
0.16
Serum vitamin B12 (ρg/ml)
-0.03
0.71
Serum folate (ηg/ml)
-0.18
0.04
*Correlation analyses were carried out by Spearman’s correlation test

DISCUSSION
Folic acid and vitamin B12 are essential dietary
components for humans, because they are required for
DNA synthesis.7 Haematopoietic cells (having a very
high turnover) are especially sensitive to deficiencies
of folate and vitamin B12. With derangement of DNA
synthesis due to deficiencies of these vitamins,
megaloblastic anaemia ensues. Since folate and
vitamin B12 deficiencies are quite common among
Pakistani individuals8, these could be the major factors
for megaloblastic anaemia in our population. In a
recently reported small study (n=50) on a hospitalbased population of patients with megaloblastic
anaemia at the Pakistan Institute of Medical Sciences,
Islamabad, the contribution of folate and B12
deficiencies was found to be 76%.3 The results of the
present study show that vitamin B12 deficiency is the
major cause of megaloblastic anaemia in patients
presenting with macrocytic anaemia at the
Haematology Clinic of AKUH over a period of 15
years. These results add credence to our previous
preliminary findings that vitamin B12 deficiency rather
than folate-deficiency is the major cause of
megaloblastosis in a population that is largely nonvegetarian. Recently, we have shown that vitamin B12
deficiency in an urban population in Karachi is nearly
10%.9 This is surprisingly a high figure considering
that most of the Pakistani population is non-vegetarian.
Four patients in the present study had severe gastritis.
They were checked for intrinsic factor antibodies
which were found to be absent in all four of them. This
shows that pernicious anaemia is not very common in
Pakistani patients with megaloblastic anaemia. More
in-depth studies are required for determining the
causes of B12 deficiency in Pakistani population. The
extent of B12 deficiency in our patient population is
similar to the one found by Khunduri and Sharma who
have reported vitamin B12 deficiency to be 65% in a
hospital-based population in Delhi and anorexia and
gastritis to be among the predominant symptoms.5
Similarly, Sarode et al have shown prevalence of
vitamin B12 deficiency to be 76% in 102 cases of
nutritional megaloblastic anaemia in a hospital in
Chandigarh.6 Though our results pertaining to high
prevalence of vitamin B12 deficiency in megaloblastic
anaemia represent a patient population largely
belonging to Southern Pakistan, yet a similar trend has
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been reported previously by Mannan et al from
Northern Pakistan.4 They have also shown that vitamin
B12 deficiency to be the major cause of megaloblastic
anaemia in patients visiting the Armed Forces Institute
of Pathology, Rawalpindi. In a small study from
Combined Military Hospital in Gilgit (Northern Areas
of Pakistan), prevalence of vitamin B12 deficiency has
been shown to be 31.8% and chronic giardiasis and
dietary insufficiency appear to be the major causes for
increased incidence of megaloblastic anaemia in that
region.10 We are mindful of the fact that inclusion of
patients in this study was based on high MCV (>96 fl),
however, concomitant deficiency of iron (which is
very common in Pakistani population) would impair
identification of several cases of vitamin B12 or folate
deficiency on the basis of macrocytosis only.11
Therefore, we suggest that prevalence of megaloblastic
anaemia due to vitamin B12 and/or folate deficiency
could be even higher in Pakistani population. Severity
of anaemia among our patients merits some discussion.
Applying WHO criteria for anaemia, 69.1% of our
patients were found to be severely anaemic (Hb <8
gm/dl). This indicates that majority of them
approached the hospital when the disease had
worsened to a great extent, and they must have been
harbouring these vitamin deficiencies for several
months. Apparently healthy people can have low
levels of vitamin B12 deficiency. With B12 deficiency
close to 10% in an apparently healthy general
population in Karachi, it is suggested that serum B12
screening should be seriously considered for
individuals showing even minor symptoms of its
deficiency.
Studies have shown an association of
neuropsychiatric disorders with vitamin B12 deficiency,
especially in the absence of anaemia or
macrocytosis,12,13 therefore, an early screening for
vitamin B12 has a merit, keeping in view the very high
costs of late treatment of irreversible neuropsychiatric
disorders arising from vitamin B12 deficiency.13

Inadequate dietary intake, over-cooking of our food and,
perhaps, poor absorption could be contributing to high
prevalence of vitamin B12 deficiency in this population.
Contrary to the general belief, vitamin B12 deficiency or
insufficiency appears to be quite common among
Pakistanis. Medical community should seriously
consider the merit of early screening (for vitamin B12) of
patients with minor symptoms of anaemia.
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